12.06.2017 • News

Australia Won’t Oppose DowDuPont

(c) Federico Rostagno/Shutterstock
(c) Federico Rostagno/Shutterstock

Australia's regulatory authority has taken DowDuPont a step closer to becoming reality with the announcement that it will not oppose a merger of the two US chemical giants Dow and DuPont.

In a statement issued late last week, the Australian Competition and Consumer Commission (ACCC) said the divestments mandated by authorities in other countries have removed any threat to competition in Australia

ACCC had said previously it had concerns the proposed merger could “substantially lessen competition in the supply of certain insecticides and material science products and reduce competitive tension in research and development of new crop protection products.”

At the time, the competition authority had expressed concern thatDow and DuPont may be the only suppliers or potential suppliers of ionomer and acid co-polymer materials to plastics manufacturers in Australia, and the merger would remove competition between them.”

ACCC also said it would look at the two groups’ existing overlap in a large number of agrochemical product areas, such as insecticides for chewing and sucking pests as well as studying the merger’s effect on canola seed innovation.

In announcing that the authority was dropping its opposition, its commissioner, Mick Keogh, said ACCC had worked closely with the European Commission, the US Department of Justice, the Canadian Competition Bureau and the New Zealand Commerce Commission in assessing the merger.

"As the remedies provided to other regulators have resolved competition concerns in Australia, the ACCC has taken a pragmatic approach and not sought standalone remedies in Australia," he said. Dow AgroSciences employs around 230 people in Australia and 115 in New Zealand.

ACCC said it is currently undertaking similar reviews of competition questions for the proposed Bayer-Monsanto deal.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.